Hong Kong Researchers Develop Oral Covid-19 Treatment

Hong Kong researchers have discovered a new combination of drugs that could work as an orally administered Covid-19 treatment.

The broad-spectrum antiviral medication has the potential to facilitate treatment at home and reduce the burden at hospitals, they say

Researchers from the University of Hong Kong evaluated the combined use of clinically used drugs, colloidal bismuth subcitrate (CBS) and N-acetyl cysteine (NAC), and found that the cocktail therapy — a combination of two or more drugs — suppresses the replication cycle of the virus, reduces viral loads in the lung and ameliorates virus-induced pneumonia in a hamster infection model, according to the paper published in the journal of Chemical Science.